nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—Parkinson's disease	0.49	0.588	CbGaD
Linezolid—MAOA—Parkinson's disease	0.344	0.412	CbGaD
Linezolid—MAOA—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOB—Parkinson's disease	0.00939	0.0759	CbGpPWpGaD
Linezolid—MAOA—locus ceruleus—Parkinson's disease	0.00907	0.225	CbGeAlD
Linezolid—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—Parkinson's disease	0.00837	0.0676	CbGpPWpGaD
Linezolid—MAOA—Amine Oxidase reactions—MAOB—Parkinson's disease	0.00539	0.0436	CbGpPWpGaD
Linezolid—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—Parkinson's disease	0.00529	0.0427	CbGpPWpGaD
Linezolid—MAOB—Amine Oxidase reactions—MAOA—Parkinson's disease	0.00481	0.0388	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—SNCAIP—Parkinson's disease	0.00471	0.038	CbGpPWpGaD
Linezolid—MAOA—Clearance of dopamine—SLC6A3—Parkinson's disease	0.0045	0.0363	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—DDC—Parkinson's disease	0.00398	0.0321	CbGpPWpGaD
Linezolid—MAOA—Clearance of dopamine—COMT—Parkinson's disease	0.00382	0.0309	CbGpPWpGaD
Linezolid—MAOB—nerve—Parkinson's disease	0.00318	0.0787	CbGeAlD
Linezolid—MAOA—Biogenic Amine Synthesis—DBH—Parkinson's disease	0.00303	0.0245	CbGpPWpGaD
Linezolid—MAOA—nerve—Parkinson's disease	0.00271	0.0672	CbGeAlD
Linezolid—MAOB—Alpha-synuclein signaling—PARK7—Parkinson's disease	0.0027	0.0218	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—DDC—Parkinson's disease	0.00249	0.0202	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—UCHL1—Parkinson's disease	0.00247	0.02	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—GRK5—Parkinson's disease	0.00241	0.0195	CbGpPWpGaD
Linezolid—MAOB—hindbrain—Parkinson's disease	0.00238	0.059	CbGeAlD
Linezolid—MAOB—Dopamine metabolism—NQO1—Parkinson's disease	0.00225	0.0182	CbGpPWpGaD
Linezolid—MAOA—Biogenic Amine Synthesis—DDC—Parkinson's disease	0.00222	0.018	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—TH—Parkinson's disease	0.00222	0.0179	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—SNCA—Parkinson's disease	0.00216	0.0175	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—MAOB—Parkinson's disease	0.0021	0.017	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.00205	0.0166	CbGpPWpGaD
Linezolid—MAOA—hindbrain—Parkinson's disease	0.00203	0.0503	CbGeAlD
Linezolid—MAOB—Dopamine metabolism—SOD1—Parkinson's disease	0.00192	0.0155	CbGpPWpGaD
Linezolid—Rivaroxaban—ABCB1—Parkinson's disease	0.00191	1	CrCbGaD
Linezolid—MAOB—Dopamine metabolism—COMT—Parkinson's disease	0.00188	0.0152	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—MAOA—Parkinson's disease	0.00187	0.0151	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—Parkinson's disease	0.00174	0.0141	CbGpPWpGaD
Linezolid—MAOA—Norepinephrine Neurotransmitter Release Cycle—SLC18A2—Parkinson's disease	0.00164	0.0132	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—PARK2—Parkinson's disease	0.00154	0.0124	CbGpPWpGaD
Linezolid—MAOB—embryo—Parkinson's disease	0.00149	0.0369	CbGeAlD
Linezolid—MAOB—Tryptophan metabolism—DDC—Parkinson's disease	0.00145	0.0117	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—NQO1—Parkinson's disease	0.00141	0.0114	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—TH—Parkinson's disease	0.00139	0.0112	CbGpPWpGaD
Linezolid—MAOB—brainstem—Parkinson's disease	0.00136	0.0338	CbGeAlD
Linezolid—MAOB—forebrain—Parkinson's disease	0.00132	0.0326	CbGeAlD
Linezolid—MAOA—embryo—Parkinson's disease	0.00127	0.0315	CbGeAlD
Linezolid—MAOA—Biogenic Amine Synthesis—TH—Parkinson's disease	0.00124	0.01	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—SOD1—Parkinson's disease	0.00121	0.00975	CbGpPWpGaD
Linezolid—MAOA—Dopamine metabolism—COMT—Parkinson's disease	0.00118	0.00956	CbGpPWpGaD
Linezolid—MAOA—brainstem—Parkinson's disease	0.00116	0.0288	CbGeAlD
Linezolid—MAOA—forebrain—Parkinson's disease	0.00112	0.0278	CbGeAlD
Linezolid—MAOB—cardiovascular system—Parkinson's disease	0.00111	0.0276	CbGeAlD
Linezolid—MAOB—Alpha-synuclein signaling—SLC6A3—Parkinson's disease	0.00111	0.00894	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—TH—Parkinson's disease	0.00111	0.00894	CbGpPWpGaD
Linezolid—MAOA—Biogenic Amine Synthesis—COMT—Parkinson's disease	0.00105	0.00852	CbGpPWpGaD
Linezolid—MAOB—medulla oblongata—Parkinson's disease	0.000952	0.0236	CbGeAlD
Linezolid—MAOA—cardiovascular system—Parkinson's disease	0.00095	0.0235	CbGeAlD
Linezolid—MAOB—midbrain—Parkinson's disease	0.00087	0.0215	CbGeAlD
Linezolid—MAOB—spinal cord—Parkinson's disease	0.000849	0.021	CbGeAlD
Linezolid—MAOA—Neurotransmitter Release Cycle—SLC18A2—Parkinson's disease	0.00083	0.00671	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000828	0.00669	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.000821	0.00664	CbGpPWpGaD
Linezolid—MAOA—medulla oblongata—Parkinson's disease	0.000812	0.0201	CbGeAlD
Linezolid—MAOB—head—Parkinson's disease	0.000754	0.0187	CbGeAlD
Linezolid—MAOA—midbrain—Parkinson's disease	0.000742	0.0184	CbGeAlD
Linezolid—MAOA—spinal cord—Parkinson's disease	0.000724	0.0179	CbGeAlD
Linezolid—MAOA—Oxidative Stress—NQO1—Parkinson's disease	0.000723	0.00584	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.000723	0.00584	CbGpPWpGaD
Linezolid—MAOB—nervous system—Parkinson's disease	0.000715	0.0177	CbGeAlD
Linezolid—MAOB—central nervous system—Parkinson's disease	0.000688	0.017	CbGeAlD
Linezolid—MAOB—cerebellum—Parkinson's disease	0.000673	0.0167	CbGeAlD
Linezolid—MAOA—Serotonin Transporter Activity—IL1B—Parkinson's disease	0.000649	0.00524	CbGpPWpGaD
Linezolid—MAOA—head—Parkinson's disease	0.000643	0.0159	CbGeAlD
Linezolid—MAOA—Oxidative Stress—SOD1—Parkinson's disease	0.000618	0.00499	CbGpPWpGaD
Linezolid—MAOA—nervous system—Parkinson's disease	0.00061	0.0151	CbGeAlD
Linezolid—MAOA—Neurotransmitter Release Cycle—HSPA8—Parkinson's disease	0.000602	0.00487	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—HMOX1—Parkinson's disease	0.000595	0.00481	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000593	0.00479	CbGpPWpGaD
Linezolid—MAOA—central nervous system—Parkinson's disease	0.000587	0.0145	CbGeAlD
Linezolid—MAOA—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000576	0.00465	CbGpPWpGaD
Linezolid—MAOA—cerebellum—Parkinson's disease	0.000574	0.0142	CbGeAlD
Linezolid—MAOA—Oxidative Stress—SOD2—Parkinson's disease	0.000556	0.0045	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000548	0.00443	CbGpPWpGaD
Linezolid—MAOB—brain—Parkinson's disease	0.000547	0.0135	CbGeAlD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000543	0.00438	CbGpPWpGaD
Linezolid—MAOA—Oxidative Stress—GPX1—Parkinson's disease	0.000531	0.00429	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—HCN3—Parkinson's disease	0.000509	0.00411	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000501	0.00405	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTA4—Parkinson's disease	0.000476	0.00384	CbGpPWpGaD
Linezolid—MAOA—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000468	0.00379	CbGpPWpGaD
Linezolid—MAOA—brain—Parkinson's disease	0.000466	0.0115	CbGeAlD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000446	0.00361	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000428	0.00346	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000372	0.00301	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.00037	0.00299	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000342	0.00276	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00034	0.00275	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—KCNJ4—Parkinson's disease	0.000328	0.00265	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2D6—Parkinson's disease	0.000315	0.00255	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTA4—Parkinson's disease	0.000298	0.00241	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000289	0.00234	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—CYP2E1—Parkinson's disease	0.000288	0.00233	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—DLG1—Parkinson's disease	0.000283	0.00229	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—MAOB—Parkinson's disease	0.000266	0.00215	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000246	0.00199	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—COMT—Parkinson's disease	0.000239	0.00193	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000238	0.00192	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTP1—Parkinson's disease	0.000238	0.00192	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—MAOA—Parkinson's disease	0.000237	0.00192	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00023	0.00186	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIK1—Parkinson's disease	0.000222	0.00179	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000221	0.00179	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—GSTM1—Parkinson's disease	0.000218	0.00177	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000218	0.00176	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2D6—Parkinson's disease	0.000198	0.0016	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000191	0.00154	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000188	0.00152	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIK2—Parkinson's disease	0.000188	0.00152	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—SLC18A2—Parkinson's disease	0.000182	0.00147	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—CYP2E1—Parkinson's disease	0.000181	0.00146	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000173	0.0014	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000162	0.00131	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000158	0.00128	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000156	0.00126	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000155	0.00125	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MCCC1—Parkinson's disease	0.000155	0.00125	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ND3—Parkinson's disease	0.000155	0.00125	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—COMT—Parkinson's disease	0.00015	0.00121	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTP1—Parkinson's disease	0.000149	0.00121	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TALDO1—Parkinson's disease	0.000146	0.00118	CbGpPWpGaD
Linezolid—MAOB—Metabolism—OMD—Parkinson's disease	0.000146	0.00118	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—CHRNA4—Parkinson's disease	0.000144	0.00117	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NDUFB11—Parkinson's disease	0.000138	0.00112	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000138	0.00111	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GSTM1—Parkinson's disease	0.000137	0.00111	CbGpPWpGaD
Linezolid—MAOA—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000133	0.00107	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—HSPA8—Parkinson's disease	0.000132	0.00107	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GCH1—Parkinson's disease	0.000132	0.00106	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000131	0.00106	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—DLG4—Parkinson's disease	0.000124	0.001	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—GRIN2B—Parkinson's disease	0.000121	0.000981	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—SLC6A3—Parkinson's disease	0.00012	0.000967	CbGpPWpGaD
Linezolid—MAOB—Metabolism—FBP1—Parkinson's disease	0.000117	0.000948	CbGpPWpGaD
Linezolid—MAOB—Metabolism—DBH—Parkinson's disease	0.000117	0.000948	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GBA—Parkinson's disease	0.000117	0.000948	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—COMT—Parkinson's disease	0.000102	0.000822	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MCCC1—Parkinson's disease	9.72e-05	0.000785	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ND3—Parkinson's disease	9.72e-05	0.000785	CbGpPWpGaD
Linezolid—MAOA—Metabolism—OMD—Parkinson's disease	9.14e-05	0.000738	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TALDO1—Parkinson's disease	9.14e-05	0.000738	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NDUFB11—Parkinson's disease	8.66e-05	0.0007	CbGpPWpGaD
Linezolid—MAOB—Metabolism—DDC—Parkinson's disease	8.61e-05	0.000696	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GCH1—Parkinson's disease	8.26e-05	0.000668	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTA4—Parkinson's disease	8.13e-05	0.000657	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	7.77e-05	0.000628	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	7.75e-05	0.000627	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GBA—Parkinson's disease	7.36e-05	0.000595	CbGpPWpGaD
Linezolid—MAOA—Metabolism—DBH—Parkinson's disease	7.36e-05	0.000595	CbGpPWpGaD
Linezolid—MAOA—Metabolism—FBP1—Parkinson's disease	7.36e-05	0.000595	CbGpPWpGaD
Linezolid—MAOB—Metabolism—PLA2G6—Parkinson's disease	7.32e-05	0.000592	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.64e-05	0.000456	CbGpPWpGaD
Linezolid—MAOA—Metabolism—DDC—Parkinson's disease	5.4e-05	0.000437	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2D6—Parkinson's disease	5.39e-05	0.000435	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CTGF—Parkinson's disease	5.29e-05	0.000427	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTA4—Parkinson's disease	5.1e-05	0.000413	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2E1—Parkinson's disease	4.93e-05	0.000398	CbGpPWpGaD
Linezolid—MAOB—Metabolism—NQO1—Parkinson's disease	4.87e-05	0.000394	CbGpPWpGaD
Linezolid—MAOB—Metabolism—TH—Parkinson's disease	4.8e-05	0.000388	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYCS—Parkinson's disease	4.61e-05	0.000373	CbGpPWpGaD
Linezolid—MAOA—Metabolism—PLA2G6—Parkinson's disease	4.6e-05	0.000371	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.55e-05	0.000368	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MAOB—Parkinson's disease	4.55e-05	0.000368	CbGpPWpGaD
Linezolid—MAOB—Metabolism—COMT—Parkinson's disease	4.08e-05	0.00033	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTP1—Parkinson's disease	4.06e-05	0.000328	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MAOA—Parkinson's disease	4.05e-05	0.000328	CbGpPWpGaD
Linezolid—MAOB—Metabolism—HMOX1—Parkinson's disease	4.01e-05	0.000324	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ABCB1—Parkinson's disease	3.85e-05	0.000311	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GSTM1—Parkinson's disease	3.73e-05	0.000302	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GPX1—Parkinson's disease	3.58e-05	0.000289	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2D6—Parkinson's disease	3.38e-05	0.000273	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CTGF—Parkinson's disease	3.32e-05	0.000268	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MTHFR—Parkinson's disease	3.3e-05	0.000267	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2E1—Parkinson's disease	3.09e-05	0.00025	CbGpPWpGaD
Linezolid—MAOB—Metabolism—APOE—Parkinson's disease	3.07e-05	0.000248	CbGpPWpGaD
Linezolid—MAOA—Metabolism—NQO1—Parkinson's disease	3.06e-05	0.000247	CbGpPWpGaD
Linezolid—MAOA—Metabolism—TH—Parkinson's disease	3.01e-05	0.000244	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYCS—Parkinson's disease	2.89e-05	0.000234	CbGpPWpGaD
Linezolid—MAOB—Metabolism—INS—Parkinson's disease	2.63e-05	0.000212	CbGpPWpGaD
Linezolid—MAOA—Metabolism—COMT—Parkinson's disease	2.56e-05	0.000207	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTP1—Parkinson's disease	2.55e-05	0.000206	CbGpPWpGaD
Linezolid—MAOA—Metabolism—HMOX1—Parkinson's disease	2.52e-05	0.000203	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ABCB1—Parkinson's disease	2.41e-05	0.000195	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GSTM1—Parkinson's disease	2.34e-05	0.000189	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GPX1—Parkinson's disease	2.24e-05	0.000181	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MTHFR—Parkinson's disease	2.07e-05	0.000167	CbGpPWpGaD
Linezolid—MAOA—Metabolism—APOE—Parkinson's disease	1.93e-05	0.000156	CbGpPWpGaD
Linezolid—MAOA—Metabolism—INS—Parkinson's disease	1.65e-05	0.000133	CbGpPWpGaD
